Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples